Literature DB >> 32492249

Conditional safety margins for less conservative peak local SAR assessment: A probabilistic approach.

Ettore Flavio Meliadò1,2,3, Alessandro Sbrizzi1,2, Cornelis A T van den Berg2,4, Bart R Steensma1,2, Peter R Luijten1, Alexander J E Raaijmakers1,2,5.   

Abstract

PURPOSE: The introduction of a linear safety factor to address peak local specific absorption rate (pSAR10g ) uncertainties (eg, intersubject variation, modeling inaccuracies) bears one considerable drawback: It often results in over-conservative scanning constraints. We present a more efficient approach to define a variable safety margin based on the conditional probability density function of the effectively obtained pSAR10g value, given the estimated pSAR10g value.
METHODS: The conditional probability density function can be estimated from previously simulated data. A representative set of true and estimated pSAR10g samples was generated by means of our database of 23 subject-specific models with an 8-fractionated dipole array for prostate imaging at 7 T. The conditional probability density function was calculated for each possible estimated pSAR10g value and used to determine the corresponding safety margin with an arbitrary low probability of underestimation. This approach was applied to five state-of-the-art local SAR estimation methods, namely: (1) using just the generic body model "Duke"; (2) using our model library to assess the maximum pSAR10g value over all models; (3) using the most representative "local SAR model"; (4) using the five most representative local SAR models; and (5) using a recently developed deep learning-based method.
RESULTS: Compared with the more conventional safety factor, the conditional safety-margin approach results in lower (up to 30%) mean overestimation for all investigated local SAR estimation methods.
CONCLUSION: The proposed probabilistic approach for pSAR10g correction allows more accurate local SAR assessment with much lower overestimation, while a predefined level of underestimation is accepted (eg, 0.1%).
© 2020 The Authors. Magnetic Resonance in Medicine published by Wiley Periodicals LLC on behalf of International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  SAR model library; SAR model selection; parallel transmit; safety factor; specific absorption rate; subject-specific local SAR assessment

Mesh:

Year:  2020        PMID: 32492249      PMCID: PMC7540599          DOI: 10.1002/mrm.28335

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


INTRODUCTION

Ultrahigh‐field MRI (UHF‐MRI) provides strong potential to achieve superior image quality compared with the current clinical systems at lower field strengths. , , To address problems with B1 homogeneity, often local multitransmit coil arrays are used. , , , , However, their application is restricted by the limits of the current methods for local specific absorption rate (SAR) assessment. , Multitransmit arrays produce a great variability of the electric field, and thereby of the absorbed power by the tissues, , , , , , , making the local SAR difficult to predict, which contributes to making the local SAR limits more restrictive than the global SAR limits (as described in IEC 60601‐2‐33). The local SAR cannot be measured during an MRI examination and is usually evaluated by numerical simulations. , , , , , , , , New software tools to perform on‐line simulations using patient‐specific body models are being developed but are still quite time‐consuming. Therefore, typically the electric‐field distribution of each array element is simulated off‐line on one or several generic models. After domain reduction by virtual observation points, , , the peak 10g average SAR (pSAR10g) for a given drive setting of the array is calculated on‐line at the scanner. Despite the previously mentioned progress, the resulting predicted SAR can still deviate from the true peak local SAR value in the patient being scanned. This is due to a variety of uncertainties in the actual examination setup. Indeed, even assuming that the reflected/lost power is properly monitored, and that there are no calibration errors, the used body model and its position within the MRI system could be very different compared with the patient under examination. To address this, a library of models can be used to cover a large patient population. , , , , , , , Nevertheless, the residual uncertainties may still result in peak local SAR overestimation or underestimation error. Although the overestimation error results in unnecessarily long scan times and/or suboptimal image quality, only peak local SAR underestimation error poses a safety risk. For this reason, to diminish the probability of underestimation, a linear safety factor is usually applied to increase the estimated peak local SAR value to such an extent that underestimation will not occur. , , , This increased estimated peak local SAR level will be referred to as the “corrected” peak local SAR value. Recently, an alternative deep learning–based method for subject‐specific SAR estimation was presented. This data‐driven approach consists of training a convolutional neural network to map the relation between subject‐specific complex maps and the corresponding local SAR distribution. However, like the aforementioned methods, this method also suffers from residual underestimation errors that need to be addressed by applying a suitable safety factor. As this study will show, the conventionally applied linear safety factor often results in unnecessary very conservative estimation, in particular when high peak local SAR value is estimated. Therefore, we propose an alternative approach to diminish the probability of peak local SAR underestimation based on the conditional probability density function of the true peak local SAR value, given the estimated peak local SAR value. This approach allows us to define a variable safety margin for each possible estimated peak local SAR value. This approach is applied to five state‐of‐the‐art local SAR estimation methods: local SAR prediction based on (1) one generic model, (2) the largest value in a large database of models, , , (3) the model that fits best the subject in the scanner, (4) a combination of methods 2 and 3, and (5) a deep learning method. In the present work, these methods are applied to assess the peak local SAR with a multitransmit array of eight fractionated dipole antennas for prostate imaging at 7 T. , For each method, the mean peak local SAR overestimation is evaluated for the conventional approach using one linear safety factor and the proposed approach, based on the probability density function. The results show that the proposed approach is better able to deal with the remaining uncertainty and reduces peak local SAR overestimation with respect to all other investigated local SAR estimation methods. In addition to the introduction of the conditional safety margin (CSM) approach based on the probability density function, this study presents a comparative evaluation of five potential local SAR assessment techniques that were described previously.

THEORY

The introduction of a linear safety factor to avoid peak local SAR (pSAR10g) underestimation bears one considerable drawback: If the estimated pSAR10g level is high, then the resulting corrected pSAR10g level shows severe overestimation of the true pSAR10g level. This is depicted in Figure 1. This figure shows for a certain transmit array configuration how estimated pSAR10g (pSARE) and truly obtained pSAR10g (pSART) are related. In particular, each point in the scatter plot represents one out of 5750 pSAR10g estimations by the deep learning method with 8 × 1W input power and random phase shimming. The diagonal red dotted line indicates where the estimated pSAR10g levels and true pSAR10g levels are equal. Points above the diagonal represent true pSAR10g levels larger than the corresponding estimate. The scatter plot clearly shows that there is a good correlation between estimated pSAR10g level and true pSAR10g level. However, the estimated pSAR10g level needs to be corrected to avoid underestimation, as there are many points above the dotted line. A linear safety factor of 1.62 is therefore determined to correct (increase) the estimated pSAR10g level, such that all of the potential true pSAR10g levels are lower than the corrected pSAR10g level.
Figure 1

Scatter plot of the true peak local specific absorption rate (pSAR10g) versus the estimated pSAR10g for 7T prostate imaging using a wide variety of random phase settings and 23 human models. The estimated pSAR10g is the pSAR10g value as determined by the deep learning–based method using simulated distributions as input. The true pSAR10g is given by the simulated pSAR10g value. The diagonal red dotted line indicates where the estimated pSAR10g and true pSAR10g values are equal. The dashed red line denotes the corrected pSAR10g using the linear safety factor (LSF), defined to avoid underestimation errors in all cases evaluated (LSF = 1.62). The solid red line is the corrected pSAR10g by the LSF defined by removing the outliers (LSF = 1.36). The blue line is the 99.9% certain pSAR10g upper bound (3.8 W/kg) for random phase settings

Scatter plot of the true peak local specific absorption rate (pSAR10g) versus the estimated pSAR10g for 7T prostate imaging using a wide variety of random phase settings and 23 human models. The estimated pSAR10g is the pSAR10g value as determined by the deep learning–based method using simulated distributions as input. The true pSAR10g is given by the simulated pSAR10g value. The diagonal red dotted line indicates where the estimated pSAR10g and true pSAR10g values are equal. The dashed red line denotes the corrected pSAR10g using the linear safety factor (LSF), defined to avoid underestimation errors in all cases evaluated (LSF = 1.62). The solid red line is the corrected pSAR10g by the LSF defined by removing the outliers (LSF = 1.36). The blue line is the 99.9% certain pSAR10g upper bound (3.8 W/kg) for random phase settings The red dashed line shows how each estimated pSAR10g level on the horizontal axis results in a corrected pSAR10g (pSARE,C) level. If the correction factor is chosen appropriately, all points will be below the dashed red line. As Figure 1 shows, this condition is fulfilled. However, the figure also clearly illustrates that for large estimated pSAR10g levels, the application of the linear safety factor results in corrected pSAR10g levels that have far too high overestimation. The overestimation could be reduced by determining the safety factor using the upper outer fence. This will make the safety factor less sensitive to outliers and/or small deviations in estimated or true pSAR10g of the one point that determines its slope. Then, using the upper outer fence definition, the linear safety factor will be 1.36, as indicated by the solid red line in Figure 1. The figure shows that more than 99.9% of the points are below the line. Unfortunately, for large estimated pSAR10g levels, the corrected pSAR10g level is still much larger than what realistically could be expected. In fact, a previous study has shown that the pSAR10g level that is not exceeded for 99.9% of the cases (over all 23 models and any potential phase setting) is 3.8 W/kg. Therefore, a solution could be to combine these limits that use the corrected pSAR10g value if the value is lower than 3.8 W/kg, and set it equal to 3.8 W/kg otherwise (blue line in Figure 1). However, from a mathematical perspective, this approach is arguably not the most appropriate solution to address this problem. Instead, a probabilistic approach should be followed. In a probabilistic setting, the scatter plot in Figure 1 represents samples from the joint probability distribution of estimated and true pSAR10g values, which is described by the probability density function f (pSAR, pSAR). When a pSARE value is estimated, we would like to know the probability of pSAR10g underestimation: P(pSAR   > pSAR). Thus, one needs to know the conditional probability density function f (pSAR), which describes the probability distribution of pSART for a given pSARE value. This function is calculated in Eq. 1, where f (pSAR) is the marginal probability density function that describes the probability distribution of estimating the pSAR value regardless of pSAR (Figure 2).
Figure 2

A, Scatter plot of the true pSART versus the estimated pSARE using the deep learning method. B, Joint probability density function fpSARE, pSART ) of the estimated and true pSAR values. C, Marginal probability density function fpSARE ) of the estimated pSAR values. D, Two‐dimensional conditional probability density function fpSART |pSARE ) obtained by combining the conditional probability density functions for each possible pSARE value

A, Scatter plot of the true pSART versus the estimated pSARE using the deep learning method. B, Joint probability density function fpSARE, pSART ) of the estimated and true pSAR values. C, Marginal probability density function fpSARE ) of the estimated pSAR values. D, Two‐dimensional conditional probability density function fpSART |pSARE ) obtained by combining the conditional probability density functions for each possible pSARE value Now the probability of pSAR10g underestimation (P) (ie, the probability that the true value pSART is actually larger than some estimated value pSAR = E 1) is given as Therefore, the conditional probability density function can be calculated for the estimated pSAR = E 1 value, and the integral can be numerically evaluated to determinate a corrected pSAR value with probability of underestimation equal to an arbitrary (small) ε: This corrected pSARE,C value effectively results in a CSM that depends on the estimated pSAR10g level and that can be determined for each possible estimated pSAR value. Note that, from the observed data, a variety of approaches can be used to estimate the underlying probability density function, including kernel density estimator, histogram, and mixture models.

METHODS

The exact extent of reduction of overestimation using the proposed approach depends on the method of pSAR10g estimation. In this study, the pSAR10g values were predicted using five state‐of‐the‐art local SAR estimation methods. Then, for each estimation method, the corrected pSAR10g values were obtained by applying the linear safety factor and the proposed approach based on probability density function. To build the required set of (pSART, pSARE) samples for the purpose of this study, our database of 23 subject‐specific models with an 8‐channel transmit body array for 7T prostate imaging , was used. For each model and every array channel, finite‐difference time‐domain simulations were performed (Sim4Life; ZMT, Zürich, Switzerland), and the results were processed to obtain the true pSAR10g and the estimated pSAR10g by each method, when the transmit array is driven with different drive vectors. Three driving modes were considered: Random phase settings: Drive vectors with uniform amplitude (8 × 1W input power) and random relative phase settings with respect to the first channel (uniform distribution: ). This driving mode allows one to assess the performances during an arbitrary imaging examination in the lower abdomen region. Prostate shimmed phase settings: Drive vectors with uniform amplitude (8 × 1W input power) and relative phase normally distributed around the average prostate phase shimming set . This driving mode allows one to assess the likely performances during a prostate imaging examination. Random amplitudes and phases settings: Drive vectors with random amplitude ( ) and random relative phase settings ( ). This driving mode allows one to assess the performances even in the case of sophisticated RF pulse design strategies (eg, SPINS. k T‐points ). Two scenarios were investigated: one in which the drive vectors were normalized to 1W maximum input power per channel, and one in which the drive vectors were normalized to 8W total input power.

Peak local SAR correction

Linear safety factor

For each model, 250 different drive vectors were used to calculate the true and the estimated pSAR10g values. Then, for each pSAR10g estimation method, 5750 (23 × 250) validation sets are used to determine the required linear safety factor using the upper outer fence method as described in the section 2. The safety factor application can produce very highly corrected pSAR10g values, particularly for high estimated pSAR10g levels. In our previous study, based on the probability distribution of the true pSAR10g, we defined a 99.9% certain pSAR10g upper bounds of 3.8 W/kg and 3.2 W/kg for random phases and prostate shimmed phases, respectively. In the same way, we can define a 99.9% certain pSAR10g upper bound of 2.6 W/kg and 6.8 W/kg for random amplitudes and phase settings normalized to 1W maximum input power per channel and 8W total input power, respectively. Therefore, as explained in section 2, we can further reduce overestimation of the linear safety factor approach by combining it with these pSAR10g upper bounds, when higher corrected pSAR10g values are obtained (Figure 1, blue line).

Conditional safety margin

We assumed that the 23 models are representative of the entire patient population. Then, for each pSAR10g estimation method, the pairs‐estimated and true pSAR10g values (pSAR, pSAR) are samples from the joint probability density function f (pSAR, pSAR) (Figure 2A) that can be modeled as a Gaussian mixture (Figure 2B). The estimated pSAR10g values are samples from the marginal probability density function f (pSAR) and follow what appears to be a gamma distribution (Figure 2C). Therefore, the conditional probability density function can be calculated, and the CSM with an arbitrary small probability of underestimation ( in our study) can be determined using Equation 3 (Figure 2D). For the practical implementation of the proposed approach, the domain f (pSAR, pSAR) is discretized (eg, ∆(pSAR), ∆ (pSAR) = 0.01 W/kg) and the estimated statistical models are used to obtain the 2D array of f (pSAR, pSAR) values and the 1‐dimensional array of f (pSAR) values. Then, from the ratio between each column of the first array and the corresponding value of the second array, the 2D array of f (pSAR|pSAR) values are determined. Each column of the obtained array represents the conditional probability density function for the corresponding pSAR value, and the CSM is determined by integrating numerically along the column until the required probability of underestimation is reached (the integral along the entire column will be equal to 1). Finally, the obtained CSMs for the discretized pSAR values are interpolated on‐line to determine the CSM for any possible estimated pSAR value.

True peak local SAR

To obtain the true pSAR10g value, for each model m and each drive setting , the 10g‐averaged Q‐matrices ( 10 g) , are calculated as follows: where is the spatial location of each 10 g matrix.

Peak local SAR estimation methods

For each model m and each drive setting , the corresponding pSAR10g values are estimated using five different methods.

Generic body model

A very common approach consists of performing off‐line electromagnetic simulations using a generic body model. Then, assuming that the investigated model is representative for the current subject, on‐line pSAR10g estimation based on the actual drive scheme can be performed. To assess the performance of this method, the generic model “Duke” of the Virtual Family with 77 tissues (version 3.0; voxel resolution 0.5 × 0.5 × 0.5 mm3) is used as follows:

Model library

To cover an entire population of patients, a model library can be used to predict the maximum pSAR10g over all models. , , Therefore, for each model m, and each drive setting , the maximum pSAR10g over the other models is determined as reported in Equation 6:

Model selection

The estimation error might be reduced using a large database of models and selecting the most representative local SAR model for the patient under examination. However, in our previous work, no relationship was found between measurable body features and pSAR10g. Therefore, as presented in our preliminary study, for each model m we consider the model n, which shows the most similar worst‐case local SAR distribution with uniform amplitude (ie, for each voxel, the maximum SAR level that could possibly be achieved with 8 × 1W input power and worst‐case phase settings), as its most representative local SAR model. Indeed, the distribution contains both patient anatomy information and electric‐field information (transmit‐array information). In particular, we select the model n, which presents the distribution that minimized the RMS error with respect to the registered distribution of the model m (Supporting Information Figures S1‐S3 report the distributions, the RMS error matrix, and the most representative local SAR models). Then, for each drive setting , the pSAR10g value is estimated using model n as follows:

Multiple models selection

As results will show, the model library method results in large mean overestimation, while the model selection method has large underestimation errors. For these reasons, a good compromise could be the selection of multiple models. Using the same model selection approach of the previous method, for each model m, the group of five most representative local SAR models A is identified (Supporting Information Table S1), and the maximum pSAR10g of these five models is used to determine the performance of the multiple models selection method as follows:

Deep learning–based method

The deep learning–based method is a new image‐based method. In this data‐driven approach, a convolutional neural network is trained to learn a “surrogate SAR model” to map the relation between subject‐specific complex maps and the corresponding local SAR distribution. Therefore, for each model m and each drive setting , the simulated maps of each channel i are processed to produce the shimmed map as follows: where Nch. = 8 is the number of transmit channels. Then, with the obtained complex maps, realistic synthetic MR images are generated (magnitude and relative transmit phase maps with noise) and used to produce the input data for the trained convolutional neural network to infer the corresponding SAR10g distribution and determine the peak value, as follows: Note that the performance of the deep learning–based method is evaluated by performing a leave‐one‐out cross‐validation. This means that 23 separate times, the convolutional neural network is trained on all of the data samples from all models except for one model (22 × 250 = 5500 training samples with random phase shimming).

Performance evaluation

To assess the performance of all methods covered by this study, for each body model, 1000 test sets were generated for each driving mode. Then, using the obtained 23 000 (23 × 1000) test sets, the mean pSAR10g overestimation error of all pSAR10g estimation methods with the linear safety factor and with the proposed CSM were evaluated and compared with each other for each driving mode.

RESULTS

For each pSAR10g estimation method and for each driving mode, 5750 (23 × 250) validation sets were used to define the required linear safety factor and the CSM. For random phase and prostate shimmed‐phase drive modes, the required linear safety factors were similar and ranged from 1.36 for the deep learning method to 1.96 for the model selection method. For the amplitude and phase shimming driving mode, the obtained linear safety factors range was a bit wider, ranging from 1.22 to 2.09 for deep learning and model selection methods, respectively. To determine the joint and marginal probability density functions of each pSAR10g estimation method, each scatter plot of true versus estimated pSAR10g was fitted with a Gaussian mixture distribution (the number of Gaussian terms was determined with the Bayesian information criterion and ranged between 3 and 5), and the estimated pSAR10g histogram was fitted with a gamma distribution (MATLAB and Statistics and Machine Learning Toolbox, The MathWorks, Natick, MA). Subsequently, the conditional probability density function was determined and the CSM was evaluated to have a probability of underestimation of 0.1% ( ). All probability density functions are reported in Supporting Information Figures S4‐S8). The performances of the defined safety factors were assessed for each pSAR10g estimation method and each driving mode with 23 000 (23 × 1000) test sets. Figure 3 shows the scatter plot of true versus estimated pSAR10g considering the use of a single generic body model to evaluate the pSAR10g with random phases (Figure 3A), prostate shimmed phases (Figure 3B) and random amplitudes and phases normalized to 1W maximum input power per channel (Figure 3C), and 8W total input power (Figure 3D). The orange line denotes the corrected pSAR10g after the application of the linear safety factor. The red line denotes the corrected pSAR10g after application of the linear safety factor limited by the 99.9% certain pSAR10g upper bound (dashed blue line). The green line denotes the corrected pSAR10g using the CSM. Figure 3E shows the mean overestimation for each pSAR10g correction method.
Figure 3

Generic body model. Scatter plot of true versus estimated pSAR10g values with random phases (A), prostate shimmed phase settings (B), random amplitudes and phases normalized to 1W maximum input power per channel (C), and random amplitudes and phases normalized to 8W input total power (D). The orange line denotes the corrected pSAR10g by the LSF; the red line denotes the corrected pSAR10g by the LSF limited by the 99.9% certain pSAR10g upper bound (UB) (dashed blue line); and the green line denotes the corrected pSAR10g by the conditional safety margin (CSM). The LSF and the CSM are determined using the validation set (validation set: cyan dots; vest set: black dots). E, Bar plot of the mean pSAR10g overestimation error for each pSAR10g correction method and each driving mode

Generic body model. Scatter plot of true versus estimated pSAR10g values with random phases (A), prostate shimmed phase settings (B), random amplitudes and phases normalized to 1W maximum input power per channel (C), and random amplitudes and phases normalized to 8W input total power (D). The orange line denotes the corrected pSAR10g by the LSF; the red line denotes the corrected pSAR10g by the LSF limited by the 99.9% certain pSAR10g upper bound (UB) (dashed blue line); and the green line denotes the corrected pSAR10g by the conditional safety margin (CSM). The LSF and the CSM are determined using the validation set (validation set: cyan dots; vest set: black dots). E, Bar plot of the mean pSAR10g overestimation error for each pSAR10g correction method and each driving mode Figure 4 presents the scatter plot of true versus estimated pSAR10g and the mean overestimation considering the model library pSAR10g estimation method. Figures 5 and 6 present the same results for the model selection and multiple models selection methods, and Figure 7 presents the same plot for the deep learning method. The histogram of the pSAR10g estimation error of each pSAR10g estimation method, each driving mode, and each pSAR10g correction method is presented in Supporting information Figures S9‐S13.
Figure 4

Model library. Scatter plot of true versus estimated pSAR10g with random phases (A), prostate shimmed phase settings (B), random amplitudes and phases normalized to 1W maximum input power per channel (C), and random amplitudes and phases normalized to 8W input total power (D). The orange line denotes the corrected pSAR10g by the LSF; the red line denotes the corrected pSAR10g by the LSF limited by the 99.9% certain pSAR10g upper bound (dashed blue line); and the green line denotes the corrected pSAR10g by the CSM. The LSF and the CSM are determined using the validation set (validation set: cyan dots; test set: black dots). E, Bar plot of the mean pSAR10g overestimation error for each pSAR10g correction method and each driving mode

Figure 5

Model selection. Scatter plot of true versus estimated pSAR10g with random phases (A), prostate shimmed phase settings (B), random amplitudes and phases normalized to 1W maximum input power per channel (C), and random amplitudes and phases normalized to 8W input total power (D). The orange line denotes the corrected pSAR10g by the LSF; the red line denotes the corrected pSAR10g by LSF limited by the 99.9% certain pSAR10g upper bound (dashed blue line); and the green line denotes the corrected pSAR10g by the CSM. The LSF and the CSM are determined using the validation set (validation set: cyan dots; test set: black dots). E, Bar plot of the mean pSAR10g overestimation error for each pSAR10g correction method and each driving mode

Figure 6

Multiple models selection. Scatter plot of true versus estimated pSAR10g with random phases (A), prostate shimmed phase settings (B), random amplitudes and phases normalized to 1W maximum input power per channel (C), and random amplitudes and phases normalized to 8W input total power (D). The orange line denotes the corrected pSAR10g by the LSF; the red line denotes the corrected pSAR10g by the LSF limited by the 99.9% certain pSAR10g upper bound (dashed blue line); and the green line denotes the corrected pSAR10g by the CSM. The LSF and the CSM are determined using the validation set (validation set: cyan dots; test set: black dots). E, Bar plot of the mean pSAR10g overestimation error for each pSAR10g correction method and each driving mode

Figure 7

Deep learning. Scatter plot of true versus estimated pSAR10g with random phases (A), prostate shimmed phase settings (B), random amplitudes and phases normalized to 1W maximum input power per channel (C), and random amplitudes and phases normalized to 8W input total power (D). The orange line denotes the corrected pSAR10g by the LSF; the red line denotes the corrected pSAR10g by the LSF limited by the 99.9% certain pSAR10g upper bound (dashed blue line); and the green line denotes the corrected pSAR10g by the CSM. The LSF and the CSM are determined using the validation set (validation set: cyan dots; test set: black dots). E, Bar plot of the mean pSAR10g overestimation error for each pSAR10g correction method and each driving mode

Model library. Scatter plot of true versus estimated pSAR10g with random phases (A), prostate shimmed phase settings (B), random amplitudes and phases normalized to 1W maximum input power per channel (C), and random amplitudes and phases normalized to 8W input total power (D). The orange line denotes the corrected pSAR10g by the LSF; the red line denotes the corrected pSAR10g by the LSF limited by the 99.9% certain pSAR10g upper bound (dashed blue line); and the green line denotes the corrected pSAR10g by the CSM. The LSF and the CSM are determined using the validation set (validation set: cyan dots; test set: black dots). E, Bar plot of the mean pSAR10g overestimation error for each pSAR10g correction method and each driving mode Model selection. Scatter plot of true versus estimated pSAR10g with random phases (A), prostate shimmed phase settings (B), random amplitudes and phases normalized to 1W maximum input power per channel (C), and random amplitudes and phases normalized to 8W input total power (D). The orange line denotes the corrected pSAR10g by the LSF; the red line denotes the corrected pSAR10g by LSF limited by the 99.9% certain pSAR10g upper bound (dashed blue line); and the green line denotes the corrected pSAR10g by the CSM. The LSF and the CSM are determined using the validation set (validation set: cyan dots; test set: black dots). E, Bar plot of the mean pSAR10g overestimation error for each pSAR10g correction method and each driving mode Multiple models selection. Scatter plot of true versus estimated pSAR10g with random phases (A), prostate shimmed phase settings (B), random amplitudes and phases normalized to 1W maximum input power per channel (C), and random amplitudes and phases normalized to 8W input total power (D). The orange line denotes the corrected pSAR10g by the LSF; the red line denotes the corrected pSAR10g by the LSF limited by the 99.9% certain pSAR10g upper bound (dashed blue line); and the green line denotes the corrected pSAR10g by the CSM. The LSF and the CSM are determined using the validation set (validation set: cyan dots; test set: black dots). E, Bar plot of the mean pSAR10g overestimation error for each pSAR10g correction method and each driving mode Deep learning. Scatter plot of true versus estimated pSAR10g with random phases (A), prostate shimmed phase settings (B), random amplitudes and phases normalized to 1W maximum input power per channel (C), and random amplitudes and phases normalized to 8W input total power (D). The orange line denotes the corrected pSAR10g by the LSF; the red line denotes the corrected pSAR10g by the LSF limited by the 99.9% certain pSAR10g upper bound (dashed blue line); and the green line denotes the corrected pSAR10g by the CSM. The LSF and the CSM are determined using the validation set (validation set: cyan dots; test set: black dots). E, Bar plot of the mean pSAR10g overestimation error for each pSAR10g correction method and each driving mode The bar diagram in Figure 8 makes it easy to compare the pSAR10g estimation methods covered by this study. It shows the mean overestimation after the correction for all considered pSAR10g estimation methods for each driving mode. The deep learning–based pSAR10g estimation method outperforms conventional methods. Compared with the pSAR10g estimation methods based on the selection of the most similar models from a database, after the application of the CSM, it achieves a mean overestimation reduction of 44%‐28% for phase shimming and 13%‐9% for amplitude and phase shimming. The multiple models selection and the model selection methods are the second and third best pSAR10g estimation methods, respectively.
Figure 8

Bar plot of the mean overestimation error for each pSAR10g estimation method with random phases (A), prostate shimmed phase settings (B), random amplitudes and phases normalized to 1W maximum input power per channel (C), and random amplitudes and phases normalized to 8W input total power (D). The orange bar denotes the mean overestimation of the corrected pSAR10g by the LSF; the red bar denotes the mean overestimation of the corrected pSAR10g by the LSF limited by the 99.9% certain pSAR10g upper bound; and the green bar denotes the mean overestimation of the corrected pSAR10g by the CSM. Abbreviations: DL, deep learning model; GM, general body model; ML, model library; MMS, multiple models selection; MS, model selection

Bar plot of the mean overestimation error for each pSAR10g estimation method with random phases (A), prostate shimmed phase settings (B), random amplitudes and phases normalized to 1W maximum input power per channel (C), and random amplitudes and phases normalized to 8W input total power (D). The orange bar denotes the mean overestimation of the corrected pSAR10g by the LSF; the red bar denotes the mean overestimation of the corrected pSAR10g by the LSF limited by the 99.9% certain pSAR10g upper bound; and the green bar denotes the mean overestimation of the corrected pSAR10g by the CSM. Abbreviations: DL, deep learning model; GM, general body model; ML, model library; MMS, multiple models selection; MS, model selection

DISCUSSION

The linear safety factor is a common approach to avoid potential underestimation due to errors in predicted peak local SAR levels. , , , , This work has shown that the linear safety factor results in unnecessarily severe scanning constraints. The correction of estimated peak local SAR levels (pSAR10g) using a linear safety factor produces an overconservative pSAR10g prediction, even when the safety factor is defined with outlier rejection and a low underestimation probability is allowed. This is because for high estimated pSAR10g values, the corrected pSAR10g values are unreasonably high. If we consider the mean estimated pSAR10g value with almost all methods, it already produces corrected pSAR10g values higher than the 99.9% certain pSAR10g upper bound. Therefore, it could be reasonable to limit the corrected pSAR10g values to this upper bound. This produces a slightly higher probability of underestimation (< 0.2%) but severely reduces the mean overestimation. Such a combination of corrected pSAR10g values is in principle a first attempt at defining variable margin factors depending on the estimated SAR level. However, a more appropriate way of tackling this problem is by making use of probability theory, to take into account the statistical distribution of realistically attainable pSAR10g values. Therefore, a new approach to define a variable safety margin based on the conditional probability distribution was presented. This approach allows one to define a CSM to obtain, for each estimated pSAR10g value, a corrected pSAR10g value that will allow for only a very small predefined probability of underestimation (eg, 0.1%). The 0.1% probability pSAR10g threshold violations will be modest with rapidly decreasing likelihood for higher pSAR10g levels. Nevertheless, some users may prefer using the proposed approach with lower underestimation probabilities, such as 0.001% (Supporting information Figure S14). This approach can be applied to any pSAR10g estimation method. It was applied to five state‐of‐the‐art pSAR10g estimation methods for a multitransmit array of eight fractionated dipole antennas for prostate imaging at 7 T , with three different drive modes: random phase settings, prostate shimmed phase settings, and random amplitude and phase settings. For each examined case, 23 × 250 validation sets were used to determine the linear safety factor and the CSM. A larger number of validation sets did not produce a significant change in the determined safety factor nor in performance (Supporting Information Figure S15). Compared with the linear safety factor limited by the 99.9% certain pSAR10g upper bound, the performance increase achievable with this method depends on the accuracy of the used pSAR10g estimation method. With pSAR10g estimation methods that show a good correlation between estimated and true pSAR10g values (eg, deep learning method), the proposed approach allows a significant reduction of the mean pSAR10g overestimation (16%‐28%). For methods that have a poor performance in predicting the true peak local SAR level (one generic model or worst‐case of all models), the benefit of the proposed approach is much less pronounced. For these methods, the reduction in mean pSAR10g overestimation is less than 12%. Note that a special case exists for extremely poor estimation methods. In that case, the estimated and true pSAR10g values exhibit low correlation, or, in other words, are essentially independent; in this case, the joint probability is the product of their marginal probabilities P (pSAR, pSAR) = P (pSAR)P(pSAR). Then, the conditional probability coincides with the marginal probability of true value P(pSAR|pSAR) = P(pSAR, pSAR)/P(pSAR) = P(pSAR). This means that from the knowledge of the estimated value, nothing can be inferred, and if the CSM is defined considering , for any estimated pSAR10g the CSM will determine a corrected pSAR10g value that will approximately coincide with the 99.9% certain pSAR10g upper bound. This is more or less the case for pSAR10g prediction using one generic model with random phase settings. As indicated in Figure 3A, the scatter cloud shows very poor correlation of true pSAR10g versus estimated pSAR10g. Therefore, the CSM results in an almost horizontal line following the 3.8 W/kg 99.9% confident upper limit. Note that, for low estimated pSAR10g values, the linear safety factor produces lower corrected pSAR10g values than the conditional safety factor. Indeed, with the linear safety factor, the probability of underestimation is larger than 0.1% when a low pSAR10g value is estimated, whereas with the CSM it is 0.1% for any estimated pSAR10g value. Likewise, with the 99.9% certain pSAR10g upper bound, the probability of underestimation is larger than 0.1% when a high pSAR10g value is estimated. Moreover, because the histogram of estimated pSAR10g values follows a gamma distribution, close to the range boundaries, the number of estimated pSAR10g values is less and less. With a very small number of samples, the estimated conditional probability density function is larger (greater uncertainty) and less accurate (because it is defined as the ratio between very small numbers, the relative error is larger). These are probably the causes of the observed large overestimation for low estimated pSAR10g values and the anomalies in the conditional probability density functions outside of the feasibly estimated pSAR10g ranges (Supporting Information Figures S4‐S8). Note that the relatively large overestimation of these low expected pSAR10g values is not at all problematic, because their occurrence is quite rare. It is worth noting that, for the random amplitudes and phases settings, we assumed that each drive vector is equally likely to occur. This assumption is probably far from the truth for many RF pulse design strategies. Therefore, for the considered RF pulse type, the probability of occurrence of the drive vectors should be assessed and taken into account for the validation set generation (similarly to what has been done for prostate shimmed phase settings). Furthermore, it must be considered that the time‐dependent drive vector of these custom RF pulses produces a time‐dependent SAR distribution with the peak value in a different location for each time step. The CSM, as well as the linear safety factor, is a global factor that does not take into account the spatial distribution of the SAR. Nevertheless, it can be used to define a correction factor (CSM/pSARE) to apply to the whole SAR distribution (or virtual observation points) for each time step (in the same way that the linear safety factor is usually applied). Subsequently, the SAR distributions are integrated over time, and then the global peak SAR value can be assessed. Results on phase‐amplitude shimming have been presented for two normalization methods: normalization on maximum input power per channel and normalization on total input power. Both normalizations resulted in different scatter clouds and different CSM curves. However, the performance in terms of mean overestimation was basically equivalent (Figure 8). In addition, a comparison was made among the state‐of‐the‐art pSAR10g estimation methods. We showed that when using a single generic body model for pSAR10g estimation, a poor relation between estimated and true pSAR10g is observed and the mean overestimation error after the correction with the CSM is 89% for random phase settings, 51% for prostate shimmed phase settings, 112% for random amplitude and phase settings normalized to 1W maximum input power per channel, and 111% for random amplitude and phase settings normalized to 8W input total power (Figure 8). Figure 3 clearly shows that the point cloud does not follow the diagonal and the corrected pSAR10g values, almost coincident with the 99.9% certain pSAR10g upper bound. Thus, the proposed correction approach allows a little mean overestimation reduction (less than 10%). Similar results were found using a model library to predict pSAR10g over all models. This pSAR10g estimation is obviously more conservative and requires smaller linear safety factors (Figure 4). However, after the correction the mean overestimation was comparable with the generic body model method (82%, 50%, 103%, and 100%). In this case, the CSM allows a mean overestimation reduction from 4% to 12%, because if a low pSAR10g value is estimated over all models, it is less likely that a high true pSAR10g value is observed, and this weak relationship is exploited by the proposed correction method. The pSAR10g estimation methods based on the selection of the most similar model(s) from a database show better performance than the conventional estimation methods. If the most “similar” model is used, the pSAR10g estimation is more accurate but not very precise (Figure 5). To manage the low precision due to the intersubject pSAR10g variability, a considerable linear safety factor is required. Nevertheless, the model selection method achieves a lower mean overestimation after the correction with the proposed approach (73%, 52%, 83%, and 87%). The use of multiple models reduces the probability of underestimation due to the intersubject pSAR10g variability, and allows us to reduce the required safety factors. This results in an even lower mean overestimation error (66%, 47%, 82%, and 86%). With the CSM, an overestimation reduction up to 15% is reached with these estimation methods. The proposed pSAR10g correction method exploits the correlation between estimated and true pSAR10g levels. Therefore, with more accurate and precise pSAR10g estimation methods, the deep learning method provides the best performance (Figure 7). It reduces the mean pSAR10g overestimation by almost 30%, achieving a mean overestimation error of 41% for random phase settings and 34% for prostate shimmed phase settings. Considerable mean overestimation is still observed for random amplitude and phase shimming (75%‐76%). However, it should be noted that the neural network was trained with only phase‐shimmed training samples. This means that better performance might be obtained by training the network with amplitude and phase‐shimmed training samples. Nonetheless, even in this case the CSM allows one to reduce the mean overestimation of almost 20%. It should also be noted that the deep learning–based method makes use of a network that was trained by penalizing the underestimation error more. This was done in an attempt to avoid underestimation, yet some underestimation error remained. Therefore, the method was included in this study as one of the investigated SAR assessment methods. If the network is trained by equally penalizing the underestimation and overestimation error, the deep learning–based method would have shown a larger degree of underestimation. The points in the scatter clouds in Figure 7 would shift to the left, the linear safety factor required to avoid underestimation would increase (red lines in Figure 7 become steeper), and the linear safety factor approach would result in a larger overestimation. Therefore, the benefit of the CSM approach would appear larger. We chose to use the deep learning–based method as it was published, which results in a conservative estimate of what benefit the CSM could provide for such methods.

CONCLUSIONS

To avoid underestimation of predicted peak local SAR (pSAR10g) levels for multitransmit arrays, a safety factor is often applied to correct (increase) the predicted pSAR10g levels. This work has shown that this approach results in drastic and unnecessary overestimation of pSAR10g levels, particularly if the estimated pSAR10g level is relatively high. In this work, an alternative approach for safety margin definition is presented using probability theory. This CSM approach allows us to define a variable safety margin for each possible estimated pSAR10g value. For prostate imaging at 7 T, the proposed CSM approach results in lower mean overestimation for all investigated local SAR estimation methods. Compared with the linear safety factor in combination with the 99.9% upper bound, the reduction of overestimation up to 30% is reached for the more accurate local SAR assessment methods.

CONFLICT OF INTEREST

Mr. Meliadò is an employee of Tesla Dynamic Coils. FIGURE S1 Transverse maximum intensity projection of the worst‐case peak 10g average specific absorption rate (pSAR10g) distributions with uniform amplitude (8 × 1W input power) FIGURE S2 Root‐mean‐square error (RMSE) matrix. Each entry RMSE [n,m] represents the RMSE between the worst‐case pSAR10g distribution of the model n and the registered worst‐case pSAR10g distribution of the model m FIGURE S3 Worst‐case pSAR10g distribution of each model and registered worst‐case pSAR10g distribution of the most representative “local SAR model” FIGURE S4 Generic body model (validation set): scatter plot of the true pSART versus the estimated pSARE (first column); marginal probability density function f of the estimated pSAR values (second column); joint probability density function f pSAR of the estimated and true pSAR values (third column); and 2D conditional probability density function f obtained by combining the conditional probability density functions for each possible pSARE value (fourth column) FIGURE S5 Model library (validation set): scatter plot of the true pSART versus the estimated pSARE (first column); marginal probability density function f of the estimated pSAR values (second column); joint probability density function f pSAR of the estimated and true pSAR values (third column); and 2D conditional probability density function f obtained by combining the conditional probability density functions for each possible pSARE value (fourth column) FIGURE S6 Model selection (validation set): scatter plot of the true pSART versus the estimated pSARE (first column); marginal probability density function f of the estimated pSAR values (second column); joint probability density function f pSAR of the estimated and true pSAR values (third column); and 2D conditional probability density function f obtained by combining the conditional probability density functions for each possible pSARE value (fourth column) FIGURE S7 Multiple models selection (validation set): scatter plot of the true pSART versus the estimated pSARE (first column); marginal probability density function f of the estimated pSAR values (second column); joint probability density function f pSAR of the estimated and true pSAR values (third column); and 2D conditional probability density function f obtained by combining the conditional probability density functions for each possible pSARE value (fourth column) FIGURE S8 Deep learning (validation set): scatter plot of the true pSART versus the estimated pSARE (first column); marginal probability density f of the estimated pSAR values (second column); joint probability density function f, pSAR of the estimated and true pSAR values (third column); and 2D conditional probability density function f obtained by combining the conditional probability density functions for each possible pSARE value (fourth column) FIGURE S9 Generic body model (test set). Scatter plot of true versus estimated pSAR10g and histogram of the pSAR10g estimation error for each driving mode and each pSAR10g correction method. The linear safety factor (LSF) and the conditional safety margin (CSM) were determined using the validation set (cyan dots) FIGURE S10 Model library (test set). Scatter plot of true versus estimated pSAR10g and histogram of the pSAR10g estimation error for each driving mode and each pSAR10g correction method. The LSF and the CSM were determined using the validation set (cyan dots) FIGURE S11 Model selection (test set). Scatter plot of true versus estimated pSAR10g and histogram of the pSAR10g estimation error for each driving mode and each pSAR10g correction method. The LSF and the CSM were determined using the validation set (cyan dots) FIGURE S12 Multiple models selection (test set). Scatter plot of true versus estimated pSAR10g and histogram of the pSAR10g estimation error for each driving mode and each pSAR10g correction method. The LSF and the CSM were determined using the validation set (cyan dots) FIGURE S13 Deep learning (test set). Scatter plot of true versus estimated pSAR10g and histogram of the pSAR10g estimation error for each driving mode and each pSAR10g correction method. The LSF and the CSM were determined using the validation set (cyan dots) FIGURE S14 A, Scatter plot of true versus estimated pSAR10g using the deep learning method with random phase settings (test set: black dots; validation set: cyan dots). The orange line denotes the corrected pSAR10g by the LSF based on the worst‐case ratio of true and estimated pSAR10g. The green line denotes the corrected pSAR10g by the CSM with probability of underestimation of 0.001% (ε = 0.00001). B, Histogram of the pSAR10g estimation error for the corrected pSAR10g by the LSF. C, Histogram of the pSAR10g estimation error for the corrected pSAR10g by the CSM. The LSF and the CSM were determined using the validation set FIGURE S15 A, Scatter plot of true versus estimated pSAR10g using the deep learning method with random phase settings (23 × 1000 validation sets: black dots; 23 × 250 validation sets: cyan dots). The orange line denotes the corrected pSAR10g by the LSF determined with 23 × 1000 validation sets (LSF = 1.37). It practically coincides with the corrected pSAR10g by the LSF determined with 23 × 250 validation sets (LSF = 1.36). The solid and dotted green lines denote the corrected pSAR10g by the CSM determined with 23 × 1000 validation sets and with 23 × 250 validation sets, respectively (ε = 0.001). B, Histogram of the pSAR10g estimation error for the corrected pSAR10g by the LSF determined with 23 × 1000 validation sets. C, Histogram of the pSAR10g estimation error for the corrected pSAR10g by the CSM determined with 23 × 1000 validation sets TABLE S1 The five most representative local SAR models for each model Click here for additional data file.
  28 in total

1.  7T vs. 4T: RF power, homogeneity, and signal-to-noise comparison in head images.

Authors:  J T Vaughan; M Garwood; C M Collins; W Liu; L DelaBarre; G Adriany; P Andersen; H Merkle; R Goebel; M B Smith; K Ugurbil
Journal:  Magn Reson Med       Date:  2001-07       Impact factor: 4.668

2.  A specific absorption rate prediction concept for parallel transmission MR.

Authors:  Ingmar Graesslin; Hanno Homann; Sven Biederer; Peter Börnert; Kay Nehrke; Peter Vernickel; Giel Mens; Paul Harvey; Ulrich Katscher
Journal:  Magn Reson Med       Date:  2012-01-09       Impact factor: 4.668

3.  Fast design of local N-gram-specific absorption rate-optimized radiofrequency pulses for parallel transmit systems.

Authors:  Alessandro Sbrizzi; Hans Hoogduin; Jan J Lagendijk; Peter Luijten; Gerard L G Sleijpen; Cornelis A T van den Berg
Journal:  Magn Reson Med       Date:  2011-11-29       Impact factor: 4.668

4.  A Histogram Transform for ProbabilityDensity Function Estimation.

Authors:  Ezequiel López-Rubio
Journal:  IEEE Trans Pattern Anal Mach Intell       Date:  2014-04       Impact factor: 6.226

5.  Intersubject local SAR variation for 7T prostate MR imaging with an eight-channel single-side adapted dipole antenna array.

Authors:  Ozlem Ipek; Alexander J Raaijmakers; Jan J Lagendijk; Peter R Luijten; Cornelis A T van den Berg
Journal:  Magn Reson Med       Date:  2013-06-10       Impact factor: 4.668

6.  Toward individualized SAR models and in vivo validation.

Authors:  H Homann; P Börnert; H Eggers; K Nehrke; O Dössel; I Graesslin
Journal:  Magn Reson Med       Date:  2011-05-31       Impact factor: 4.668

7.  Tailored excitation in 3D with spiral nonselective (SPINS) RF pulses.

Authors:  Shaihan J Malik; Shiva Keihaninejad; Alexander Hammers; Joseph V Hajnal
Journal:  Magn Reson Med       Date:  2011-08-12       Impact factor: 4.668

8.  System and SAR characterization in parallel RF transmission.

Authors:  Yudong Zhu; Leeor Alon; Cem M Deniz; Ryan Brown; Daniel K Sodickson
Journal:  Magn Reson Med       Date:  2011-12-02       Impact factor: 4.668

9.  The Virtual Family--development of surface-based anatomical models of two adults and two children for dosimetric simulations.

Authors:  Andreas Christ; Wolfgang Kainz; Eckhart G Hahn; Katharina Honegger; Marcel Zefferer; Esra Neufeld; Wolfgang Rascher; Rolf Janka; Werner Bautz; Ji Chen; Berthold Kiefer; Peter Schmitt; Hans-Peter Hollenbach; Jianxiang Shen; Michael Oberle; Dominik Szczerba; Anthony Kam; Joshua W Guag; Niels Kuster
Journal:  Phys Med Biol       Date:  2009-12-17       Impact factor: 3.609

10.  Comparing signal-to-noise ratio for prostate imaging at 7T and 3T.

Authors:  Bart R Steensma; Mariska Luttje; Ingmar J Voogt; Dennis W J Klomp; Peter R Luijten; Cornelis A T van den Berg; Alexander J E Raaijmakers
Journal:  J Magn Reson Imaging       Date:  2018-10-22       Impact factor: 4.813

View more
  2 in total

1.  Conditional safety margins for less conservative peak local SAR assessment: A probabilistic approach.

Authors:  Ettore Flavio Meliadò; Alessandro Sbrizzi; Cornelis A T van den Berg; Bart R Steensma; Peter R Luijten; Alexander J E Raaijmakers
Journal:  Magn Reson Med       Date:  2020-06-03       Impact factor: 4.668

2.  Rigid motion-resolved B1+ prediction using deep learning for real-time parallel-transmission pulse design.

Authors:  Alix Plumley; Luke Watkins; Matthias Treder; Patrick Liebig; Kevin Murphy; Emre Kopanoglu
Journal:  Magn Reson Med       Date:  2021-12-27       Impact factor: 3.737

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.